Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bedford Laboratories has received FDA approval to begin shipping pentostatin for injection, for the treatment of hairy cell leukemia.
Subscribe to our email newsletter
The product is AP rated and is equivalent to Nipent by Hospira.
Bedford Laboratories will supply latex-free pentostatin for injection as a sterile lyophilized powder in a single-dose vial containing 10mg of pentostatin.